Page 1 of Clinical Trials for Alkylating Agents, 3348 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Last Updated: November 22, 2011
Condition(s): Breast Cancer; Metastases
2
Active, not recruiting
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
Last Updated: April 25, 2012
Condition(s): Chronic Lymphocytic Leukemia; Thrombocytopenia
3
Completed
506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
Last Updated: July 23, 2008
Condition(s): Leukemia
4
Recruiting
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Last Updated: March 12, 2012
Condition(s): Sarcoma; Desmoplastic Small Round Cell Tumor (DSRCT)
5
Terminated
Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers
Last Updated: February 28, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes
6
Recruiting
Total Marrow Irradiation Added to an Alkylator-Intense Conditioning Regimen for Patients With High Risk or Relapsed Solid Tumors
Last Updated: July 12, 2011
Condition(s): Brain and Central Nervous System Tumors; Kidney Cancer; Liver Cancer; Retinoblastoma; Sarcoma
7
Completed
Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer
Last Updated: March 3, 2008
Condition(s): Breast Neoplasms; Neoplasm Metastasis
8
Completed
A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer
Last Updated: March 3, 2008
Condition(s): Breast Cancer; Breast Neoplasms
9
Recruiting
Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
Last Updated: April 24, 2012
Condition(s): Indolent Non-Hodgkin Lymphoma; Follicular Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytoid Lymphoma; Marginal Zone Lymphoma
10
Completed
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer
Last Updated: November 17, 2011
Condition(s): Non-Small Cell Lung Cancer
11
Terminated
Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD
Last Updated: October 25, 2010
Condition(s): Breast Cancer
12
Completed
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Last Updated: March 27, 2008
Condition(s): Glioblastoma
13
Completed
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
Last Updated: August 24, 2009
Condition(s): Breast Cancer
14
Completed
Multicenter Uveitis Steroid Treatment (MUST) Trial
Last Updated: October 26, 2011
Condition(s): Uveitis
15
Completed
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
Last Updated: May 12, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
16
Completed
VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas
Last Updated: March 13, 2010
Condition(s): Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
17
Completed
VNP40101M in Treating Patients With Advanced or Metastatic Cancer
Last Updated: March 13, 2010
Condition(s): Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
18
Active, not recruiting
Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
Last Updated: February 19, 2012
Condition(s): Leukemia; Lymphoma
19
Active, not recruiting
Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
Last Updated: March 8, 2010
Condition(s): Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS)
20
Completed
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
Last Updated: August 24, 2011
Condition(s): Chronic Lymphocytic Leukemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Alkylating+Agents

Page 1 of Clinical Trials for Alkylating Agents, 3348 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About